Organon signs an exclusive, worldwide licence agreement on advanced antithrombotic compounds with Endotis Pharma
02-Nov-2007
Most read news
Topics
Organizations
AkzoNobel
N.V. Organon
Endotis Pharma
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.